CClinicalTrials.gg
CompletedNCT04148521VIBRANTUpdated Mar 21, 2023Results posted

A Virtual Navigation Intervention to Reduce Behavioral Health Admissions From Rural Emergency Departments

An interventional study of Behavioral Health - Virtual Patient Navigation in Depression, Anxiety and Substance Use Disorders, sponsored by Wake Forest University Health Sciences. Completed at 9 sites in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2023-03-21.

Sponsored by Wake Forest University Health Sciences · Not applicable, Interventional, and Health services research

Phase
Not applicable
Study type
Interventional
Enrollment
1,089
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

This research project is a pragmatic, randomized evaluation of a quality improvement initiative which seeks to evaluate the effects of standardizing the use of a BH-VPN program among patients with a telepsychiatric consult. The outcomes evaluation of this intervention has been designed to integrate with routine care and minimize frontline staff burden by deploying an evaluation in a real-world setting.

Read the detailed description

Hospital admissions are common amongst those with mental illness. Significant morbidity exists for patients who are being admitted to a psychiatric hospital from the Emergency Department (ED).Additionally, commitment to a hospital setting may have adverse effects on patients psychologically, degrade relationships with therapists, and disrupt continuity of care. ED providers often decide to admit to a psychiatric hospital because of limited availability of behavioral health resources. To better enhance transitions of care for those with mental illness, Atrium Health has designed a behavioral health virtual patient navigation (BH-VPN)program that helps coordinate services and follow-up care, while facilitating the safe discharge of patients. Patients presenting to an ED that have a tele psychiatric consult who are recommended for discharge are eligible for services. The Behavioral health Service line is expanding the program to additional rural emergency departments. Using an outcomes evaluation, the investigators will inform Atrium Health on the effect of the BH-VPN program to reduce hospital admissions among patients with a tele psychiatric consult in the ED. The proposed hypothesis is that by having the BH-VPN program available in an ED, more patients will be discharged from the ED than admitted.

02

Conditions studied

  • Depression
  • Anxiety
  • Substance Use Disorders
03

In context

Substance-Related Disorders

2,124 studies on the registry are indexed under Substance-Related Disorders; 393 are open to participants now.

This study's enrollment of 1,089 is above the median of 108 across 1,727 interventional studies indexed under Substance-Related Disorders.

Browse Substance-Related Disorders studies →

Lead sponsor

Wake Forest University Health Sciences is the lead sponsor of 1,320 studies on the registry; 199 are open to participants now.

Of its 323 completed or terminated interventional studies of FDA-regulated products, 243 (75%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

Inclusion Criteria:

Eligible patients must meet each of the following criteria:

  • Present to an ED at participating sites
  • Complete a telepsychiatric consult as captured in the electronic medical record
  • Complete a telepsychiatric consult during the navigator's hours of operation
  • ≥ 18 years of age at time of ED admission

Exclusion Criteria:• Patients currently enrolled in the BH-VPN program upon their index ED encounter

-

05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
1,089 participants (actual)

Study arms

  • Experimental
    Behavioral Health - Virtual Patient Navigation

    All patients who meet eligibility criteria at sites where the virtual patient navigation behavioral health program is offered will be considered exposed to the intervention.

    Behavioral: Behavioral Health - Virtual Patient Navigation

  • No intervention
    Usual care Behavioral Health

    All patients who meet eligibility criteria at sites where the virtual patient navigator behavioral health program is not offered will be considered exposed to usual care.

Interventions

  • BehavioralBehavioral Health - Virtual Patient Navigation

    Patients are identified by a clinician in the ED as needing psychiatric evaluation and a referral is made to a tele-psych provider for a virtual consult. Patients can be enrolled to the intervention arm based on a randomization scheme that randomly allocates days that navigators are available. The psychiatrist will make a recommendation to admit or discharge the patient. For patients that have a discharge recommendation on days that BH-VPN is available, patients will be offered the BH-VPN program. Enrolled patients are followed for up to 45 days. On days where the navigator is available, all patients who meet eligibility criteria will be considered exposed to the intervention.

06

What researchers measure

Primary outcomes

  1. Assessing Hospital Admissions

    Compare the effectiveness of having the Behavioral Health - Virtual Patient Navigation (BH-VPN) program available compared to usual care, on admission rates among patients in the ED with a telepsychiatric consult

    Time frame: Up to 2 weeks from initial ED admission

Secondary outcomes

  1. 45-day Post Discharge Utilization Rate

    Comparing the 45-day utilization (ED, IP, OBS encounter) rate after the ED encounter between the 2 arms of the study

    Time frame: 45 days

  2. 45-day Post Discharge Utilization Rate With a Self-harm Diagnosis

    Compare the frequency of patients with any encounter with a self-harm diagnosis within 45 days of the ED visit between the 2 arms of the study

    Time frame: 45 days

  3. 45-day Post Discharge ED Utilization Rate With a Behavioral Health Crisis

    Compare the frequency of patients who return to the ED and have a telepsychiatric consult within 45 days of their initial ED visit between the 2 arms of the study

    Time frame: 45 days

07

Results

Posted Apr 12, 2022

Participant flow

Participant flow — Overall Study
MilestoneBehavioral Health - Virtual Patient NavigationUsual Care Behavioral Health
Started534555
Completed534555
Not completed00

Outcome measures

PrimaryAssessing Hospital Admissions

Compare the effectiveness of having the Behavioral Health - Virtual Patient Navigation (BH-VPN) program available compared to usual care, on admission rates among patients in the ED with a telepsychiatric consult

Time frame:
Up to 2 weeks from initial ED admission
Reported as:
Count of participants · Participants
Assessing Hospital Admissions
ParticipantsBehavioral Health - Virtual Patient NavigationUsual Care Behavioral Health
Assessing Hospital Admissions332326
Statistical analysis
  • Behavioral Health - Virtual Patient Navigation · Mixed Models Analysis · p = 0.27 · Odds ratio (or): 1.15 · 95% CI 0.90 to 1.47
Secondary45-day Post Discharge Utilization Rate

Comparing the 45-day utilization (ED, IP, OBS encounter) rate after the ED encounter between the 2 arms of the study

Time frame:
45 days
Reported as:
Number · participants
45-day Post Discharge Utilization Rate
participantsBehavioral Health - Virtual Patient NavigationUsual Care Behavioral Health
45-day Post Discharge Utilization Rate8889
Statistical analysis
  • Behavioral Health - Virtual Patient Navigation vs Usual Care Behavioral Health · Mixed Models Analysis · p = 0.83 · Odds ratio (or): 1.04 · 95% CI 0.75 to 1.43
Secondary45-day Post Discharge Utilization Rate With a Self-harm Diagnosis

Compare the frequency of patients with any encounter with a self-harm diagnosis within 45 days of the ED visit between the 2 arms of the study

Time frame:
45 days
Reported as:
Count of participants · Participants
45-day Post Discharge Utilization Rate With a Self-harm Diagnosis
ParticipantsBehavioral Health - Virtual Patient NavigationUsual Care Behavioral Health
45-day Post Discharge Utilization Rate With a Self-harm Diagnosis4735
Statistical analysis
  • Behavioral Health - Virtual Patient Navigation vs Usual Care Behavioral Health · Mixed Models Analysis · p = 0.12 · Odds ratio (or): 1.43 · 95% CI 0.91 to 2.26
Secondary45-day Post Discharge ED Utilization Rate With a Behavioral Health Crisis

Compare the frequency of patients who return to the ED and have a telepsychiatric consult within 45 days of their initial ED visit between the 2 arms of the study

Time frame:
45 days
Reported as:
Count of participants · Participants
45-day Post Discharge ED Utilization Rate With a Behavioral Health Crisis
ParticipantsBehavioral Health - Virtual Patient NavigationUsual Care Behavioral Health
45-day Post Discharge ED Utilization Rate With a Behavioral Health Crisis4036
Statistical analysis
  • Behavioral Health - Virtual Patient Navigation vs Usual Care Behavioral Health · Mixed Models Analysis · p = 0.51 · Odds ratio (or): 1.17 · 95% CI 0.73 to 1.86

Adverse events

Collected over 15 months. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Behavioral Health - Virtual Patient Navigation0/534 (0%)0/534 (0%)0/534 (0%)
Usual Care Behavioral Health0/555 (0%)0/555 (0%)0/555 (0%)

Baseline characteristics

Age, Continuous
Age, Continuous(years)Behavioral Health - Virtual Patient NavigationUsual Care Behavioral HealthTotal
Mean41.1 ± 16.041.6 ± 15.941.4 ± 16.0
Sex: Female, Male
Sex: Female, Male(Participants)Behavioral Health - Virtual Patient NavigationUsual Care Behavioral HealthTotal
Female222248470
Male312307619
Race (NIH/OMB)
Race (NIH/OMB)(Participants)Behavioral Health - Virtual Patient NavigationUsual Care Behavioral HealthTotal
American Indian or Alaska Native000
Asian000
Native Hawaiian or Other Pacific Islander000
Black or African American9192183
White420437857
More than one race161834
Unknown or Not Reported7815
Region of Enrollment
Region of Enrollment(Participants)Behavioral Health - Virtual Patient NavigationUsual Care Behavioral HealthTotal
United States5345551089
08

Study locations

9 sites
  • Atrium Health - Stanly
    Albemarle, North Carolina 28001, United States
  • Atrium Health - Kings Mountain
    Kings Mountain, North Carolina 28086, United States
  • Scotland Memorial Hospital
    Laurinburg, North Carolina 28352, United States
  • Atrium Health - Lincoln
    Lincolnton, North Carolina 28092, United States
  • Carolinas HealthCare System - Blue Ridge - Morganton
    Morganton, North Carolina 28655, United States
  • Atrium Health - Cleveland
    Shelby, North Carolina 28150, United States
  • Carolinas HealthCare System - Valdese
    Valdese, North Carolina 28690, United States
  • Atrium Health - Anson
    Wadesboro, North Carolina 28170, United States
  • Columbus Regional Hospital
    Whiteville, North Carolina 28472, United States
09

References and documents

Study documents

  • Protocol and statistical analysis plan · Aug 27, 2019
  • Informed consent form · Oct 2, 2022

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 21, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT04148521
Lead sponsor
Wake Forest University Health Sciences
Collaborators
The Duke Endowment
Responsible party
Sponsor
First posted
Nov 1, 2019
Start date
Oct 14, 2019
Primary completion
Oct 31, 2021
Completion
Jan 31, 2022
Results posted
Apr 12, 2022
Last update
Mar 21, 2023

Study contacts

Jason Roberge, PhD
principal investigator · Wake Forest University Health Sciences

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion